Sensei Biotherapeutics Inc (SNSE)
1.52
-0.07
(-4.40%)
USD |
NASDAQ |
May 17, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
Sensei Biotherapeutics Shareholders Equity (Quarterly): 58.47M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 58.47M |
| December 31, 2023 | 64.90M |
| September 30, 2023 | 71.00M |
| June 30, 2023 | 79.20M |
| March 31, 2023 | 94.85M |
| December 31, 2022 | 103.41M |
| September 30, 2022 | 113.99M |
| June 30, 2022 | 125.92M |
| Date | Value |
|---|---|
| March 31, 2022 | 135.31M |
| December 31, 2021 | 146.51M |
| September 30, 2021 | 155.21M |
| June 30, 2021 | 163.12M |
| March 31, 2021 | 171.25M |
| December 31, 2020 | -56.44M |
| September 30, 2020 | -51.68M |
| December 31, 2019 | -68.66M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-68.66M
Minimum
Dec 2019
171.25M
Maximum
Mar 2021
81.65M
Average
99.13M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 66.70M |
| Total Liabilities (Quarterly) | 8.221M |